Municipal Risk Forensics
Forensic Pharmacy-Benefit Audits · Louisiana Public Employers

Your health plan's pharmacy bill has a number in it that nobody checks.

Parishes, school boards, and municipalities across Louisiana self-fund their employee health plans — and pay whatever the pharmacy middleman bills. We re-price every claim against the federal government's own drug-cost benchmark and show you, line by line, what your plan actually should have paid. The review costs you nothing.

Louisiana SEBD & LED Hudson Initiative certified (2026) · Registered Louisiana state vendor

The 90-Second Briefing

The receipts are public. Here is what they say.

$615,000,000
One pharmacy middleman. One health plan. One overcharge — found by a federal audit this year.
It wasn't dramatic fraud. It was the quiet kind.
Discounts negotiated but never passed through. Credits kept. Prices never checked against what the drugs actually cost.
$224.8Mhidden pharmacy "spread," in a single year — Ohio Auditor of State
$45MLouisiana's own Attorney General settlement, 2026
$7.3Bmarkups at the three largest middlemen — FTC
Every parish, school board, and municipality in Louisiana pays whatever the pharmacy middleman bills.
That bill has a number in it that, in most plans, no one ever checks.
We re-price every claim against the federal government's own drug-cost benchmark —
and show you, line by line, what your plan should have paid.
Act 474. Louisiana just outlawed the practices that hide that money.
For once, the law is on your plan's side.
No cost to look. If the review finds nothing, you owe nothing — either way, you'll know.
If there's nothing there, you'll know — and it cost nothing to find out.
Municipal Risk Forensics
Independent forensic review of public pharmacy spend · municipalriskforensics.com
Request the no-cost review
Watch the 90-second briefing

The methodology is proven — by government auditors, at national scale

$615M
Overcharge found in the federal employee health plan by the U.S. OPM Inspector General's audit of CVS Caremark (2018–2021, report released 2026)
$224.8M
One year of hidden pharmacy "spread" found by the Ohio Auditor of State (2018) — 31% margins on generic drugs
$45M
Louisiana's own Attorney General settlement with CVS/Caremark (February 2026)
$7.3B
Specialty generic-drug markups above acquisition cost at the three largest pharmacy middlemen's own affiliated pharmacies, found by the Federal Trade Commission (2017–2022)

Every figure above is from a published government report or settlement. The same benchmark-based method those auditors used is the one we apply to your plan.

The Estimator

Run your plan's numbers — right now, on your side of the table.

This applies a leakage rate a state auditor actually documented — the Ohio Auditor of State's landmark claims-level pharmacy audit — to a plan of your size. It's a model, not a finding. The point is the size of the question mark sitting in your budget, and that answering it costs you nothing.

Leave blank and we model it at a deliberately conservative $3,000 per covered employee per year. Your plan's actual pharmacy figure — the number on your TPA or CFO report — tightens this instantly.

Enter your plan details and select Calculate my estimate. Your modeled annual exposure range appears here.
How the model works: your annual pharmacy spend × 2.9% to 8.8%. The 8.8% ceiling is the overall spread rate the Ohio Auditor of State documented in its 2018 claims-level audit of that state's Medicaid managed-care pharmacy program — which found $224.8 million retained in a single year, and roughly 31% margins on generic drugs. The floor assumes a plan leaking at just one-third of that documented rate. This is a modeled estimate based on published government findings — not an audit finding about your plan, and not a statement about any specific vendor. Actual results require a claims-level review.
How It Works

Three steps. No cost, no obligation, no disruption to your plan.

1

The complimentary review

We analyze your plan's published financials, contracts, and — at your election — claims data your plan is entitled to request from its own vendors. Every drug claim is re-priced against NADAC, the federal survey of what pharmacies actually pay for drugs.

2

Findings for you and your counsel

You receive a written findings summary — what was overpaid, where, and the statutes that apply — built for your board and your own attorney. We provide forensic data analysis, not legal advice; every decision stays with you and your counsel.

3

The findings are yours. Then you decide.

If you choose to act on the findings, we support your team through it. The review itself costs nothing, and any engagement beyond it is scoped and priced with your counsel before it begins — structured to comply with Louisiana public-contract law. No surprises, in either direction.

Why Now

Louisiana just rewrote the rules in your plan's favor.

Act 474 of 2025

Louisiana banned pharmacy "spread pricing" and mandated 100% pass-through of drug-maker rebates to plans — with enforcement provisions taking effect January 1, 2027. Money kept from your plan in ways the state has now outlawed is exactly what a forensic review surfaces.

LDI Directive 257 (2026)

Louisiana's Department of Insurance declared that pharmacy reimbursement below the federal acquisition-cost benchmark plus $9.00 is per se not fair and reasonable — a regulator-endorsed version of the exact benchmark we audit against.

Federal transparency law

Federal law now prohibits contract clauses that block a plan from seeing its own claims data — including "once a year only" audit limits. Your plan is entitled to the data that proves what it paid. We help you use that right.

Our Mission

Independent, Louisiana-based, and on exactly one side: the plan's.

Municipal Risk Forensics helps public employers strengthen fiduciary oversight of their employee health plans — by identifying financial leakage, improving transparency, and providing independent analysis that supports responsible stewardship of taxpayer resources. With increasing scrutiny around healthcare costs and fiduciary accountability, our goal is to help organizations uncover savings opportunities while strengthening governance and decision-making.

We are an independent forensic audit firm built for one client: the self-funded public employer. We take no commissions from insurers, brokers, or pharmacy benefit managers — the vendors we review — and we sell nothing but the analysis itself.

The firm is led by Isiah Edwards, a licensed life & health insurance professional with multi-state licensure and deep experience in how employer health plans are actually priced, sold, and serviced. That industry background is the point: we know where the money moves because we come from the rooms where it moves.

Our audit platform re-prices every pharmacy claim against public federal benchmarks, verifies every finding against the statute that makes it actionable, and produces work built to withstand scrutiny — by your board, your counsel, and the vendors themselves.

Our Lane — Stated Plainly

Municipal Risk Forensics is a forensic data-analysis firm, not a law firm, and provides no legal advice or legal services.

Our findings are factual and analytical. Any demand, claim, or recovery action based on them is the decision of your entity, acting through its own legal counsel.

Findings are delivered confidentially to you and your counsel.

Ask us to look. It costs nothing, and you'll know — either way.

Tell us the entity and roughly how many employees are on the plan. We'll tell you what a review would examine and what the public record already shows. No cost, no obligation, and you can stop at any time.